Chronic pancreatitis

Current Opinion in Gastroenterology

Volumn 19, Issue 5, 2003, Pages 451-457

  DiMagno, Matthew J ^a   DiMagno, Eugene P ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Chronic pancreatitis; Corticosteroids; Electronic pancreatoscopy; Endoscopic pancreatic function test; Extracorporeal shock wave lithotripsy

Indexed keywords

ANTIFIBRINOLYTIC AGENT; CHOLECYSTOKININ; MEVINOLIN; SECRETIN;

ALCOHOLIC PANCREATITIS; AUTOIMMUNE DISEASE; CANCER RISK; CELL ACTIVATION; CFTR GENE; CHRONIC PANCREATITIS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DUODENOSCOPE; ELECTRONIC PANCREATOSCOPY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC THERAPY; EXTRACORPOREAL LITHOTRIPSY; FIBROGENESIS; FIBROSIS; GENE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; PANCREAS CANCER; PRSS1 GENE; REVIEW; SPINK1 GENE; STELLATE CELL; STOMACH PARESIS;

EID: 0042887552     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200309000-00003     Document Type: Review

References (75)

1. Whitcomb DC, Preston RA, Aston CE, et al.: A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology 1996, 110:1975-1980. [see comments]
2. Whitcomb DC, Gorry MC, Preston RA, et al.: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996, 14:141-145.
3. Gorry MC, Gabbaizedeh D, Furey W, et al.: Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997, 113;1063-1068.
4. Witt H, Luck W, Hennies HC, et al.: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000, 25:213-216.
5. Pfutzer RH, Barmada MM, Brunskill AP, et al.: SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000, 119:615-623.
6. Chen JM, Mercier B, Audrezet MP, Ferec C: Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet 2000, 37:67-69.
7. Noone PG, Zhou Z, Silverman LM, et al.: Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001, 121:1310-1319.
8. Ockenga J, Dork T, Stuhrmann M: Low prevalence of SPINK1 gene mutations in adult patients with chronic idiopathic pancreatitis. J Med Genet 2001, 38:243-244.
9. Truninger K, Witt H, Kock J, et al.: Mutations of the serine protease inhibitor, Kazal type 1 gene, in patients with idiopathic chronic pancreatitis. Am J Gastroenterol 2002, 97:1133-1137.
10. Threadgold J, Greenhalf W, Ellis I, et al.: The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut 2002, 50:675-681.
11. Drenth JP, te Morsche R, Jansen JB: Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 2002, 50:687-692.
12. Gaia E, Salacone P, Gallo M, et al.: Germline mutations in CFTR and PSTI genes in chronic pancreatitis patients. Dig Dis Sci 2002, 47:2416-2421.
13. Audrezet MP, Chen JM, Le Marechal C, et al.: Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet 2002, 10:100-106.
14. Cohn JA, Friedman K J, Noone PG, et al.: Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998, 339:653-658.
15. Sharer N, Schwarz M, Malone G, et al.: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998, 339:645-652.
16. Oekenga J, Stuhrmann M, Ballmann M, et al.: Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am J Gastroenterol 2000, 95:2061-2067.
17. Castellani C, Gomez Lira M, Frulloni L, et al.: et al. Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in idiopathic pancreatitis. Hum Mutat 2001, 18:166.
18. Truninger K, Malik N, Ammann RW, et al.: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. Am J Gastroenterol 2001, 96:2657-2661.
19. Groman JD, Meyer ME, Wilmott RW, et al.: Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N Engl J Med 2002, 347:401-407. Variant cystic fibrosis phenotypes were observed in patients without CFTR mutations, raising the possibility that a second class of genes may indirectly affect CFTR protein trafficking and lead to a variant cystic fibrosis phenotype.
20. Durno C, Corey M, Zielenski J, et al.: Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 2002, 123:1857-1864. This excellent study provides new information on the prevalence, natural history, and genotypic basis of pancreatitis associated with cystic fibrosis.
21. Steer ML, Meldolesi J: The cell biology of experimental pancreatitis. N Engl J Med 1987, 316:144-150.
22. Kukor Z, Toth M, Pal G, Sahin-Toth M: Human cationic trypsinogen. Arg(117) is the reactive site of an inhibitory surface loop that controls spontaneous zymogen activation. J Biol Chem 2002, 277:6111-6117.
23. Simon P, Weiss FU, Sahin-Toth M, et al.: Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 → Cys) that alters autoactivation and auto-degradation of cationic trypsinogen. J Biol Chem 2002, 277:5404-5410.
24. Witt H, Becker M: Genetics of chronic pancreatitis. J Pediatr Gastrcenterol Nutr 2002, 34:125-136.
25. Simon P, Weiss FU, Zimmer KP, et al.: Spontaneous and sporadic trypsinogen mutations in idiopathic pancreatitis. JAMA 2002, 288:2122. A provocative study showing that 10% of patients with "idiopathic panoreatitis" may have trypsinogen gene mutations.
26. Keim V, Teich N. Idiopathic vs hereditary pancreatitis. JAMA 2003, 289:983-4; author reply 985. An editorial to [24] that reviews data from prior, studies and shows that the mean prevalence of trypsinogen gene mutations in patients with "idiopathic panoreatitis" is 1.9%, with a range of 0.2 to 10%.
27. Whitcomb DC: How to think about SPINK and pancreatitis. Am J Gastroenterol 2002, 97:1085-1088. An editorial to [9] that discusses the association of SPINK1 gene mutations with pancreatic diseases and provides insight on how to interpret and apply this information clinically.
28. Bhatia E, Choudhuri G, Sikora SS, et al.: Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations. Gastroenterology 2002, 123:1020-1025.
29. Rossi L, Pfutzer RH, Parvin S, et al.: SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh. A preliminary report. Pancreatology 2001, 1:242-245.
30. Mohan V, Premalatha G, Pitchumoni CS: Tropical chronic pancreatitis: an update. J Clin Gastroenterol 2003, 36:337-346.
31. Schneider A, Suman A, Rossi L, et al.: SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology 2002, 123:1026-1030.
32. Chandak GR, Idris MM, Reddy DN, et al.: Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. J Med Genet 2002, 39:347-351.
33. Hassan Z, Mohan V, Ali L, et al.: SPINK1 is a susceptibility gene for fibrocalculous pancreatic diabetes in subjects from the Indian subcontinent. Am J Hum Genet 2002, 71:964-968.
34. Hawrami K, Mohan V, Bone A, Hitman GA: Analysis of islet regenerating (reg) gene polymorphisms in fibrocalculous pancreatic diabetes. Pancreas 1997, 14:122-125.
35. Rossi L, Whitcomb DC, Ehrlich GD, et al.: Lack of R117H mutation in the cationic trypsinogen gone in patients with tropical pancreatitis from Bangladesh. Pancreas 1998, 17:278-280.
36. Hassan Z, Mohan V, McDermott MF, et al.: Pancreatitis in fibrocalculous pancreatic diabetes mellitus is not associated with common mutations in the trypsinogen gene. Diabetes Metab Res Rev 2000, 16:454-457.
37. Bhatia E, Dude P, Ziefenski J, et al.: Mutations in the cystic fibrosis transmembrane regulator gene in patients with tropical calcific pancreatitis. Am J Gastroenterol 2000, 95:3658-3659.
38. DiMagno EP: Gene mutations and idiopathic chronic pancreatitis: clinical implications and testing. Gastroenterology 2001, 121:1508-1512.
39. Knowles MR, Durie PR: What is cystic fibrosis? N Engl J Med 2002, 347:439-442.
40. Strandvik B, Gronowitz E, Enlund F, et al.: Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J Pediatr 2001, 139:650-655.
41. Freedman SD, Katz MH, Parker EM, et al.: A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice. Proc Natl Acad Sci U S A 1999, 96:13995-14000.
42. Blanco PG, Shea JC, O'Sullivan BP, et al.: AA/DHA ratio in nasal mucosal scrapings differentiates cystic fibrosis patients from healthy and disease controis and correlates with nasal potential difference testing. Pediatr Pulmonol 2001, (Suppl 22):240-241.
43. Beckles Willson N, Elliott TM, Everard ML. Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database Syst Rev 2002, 3:CD002201.
44. Norton ID, Apte MV, Dixson H, et al.: Cystic fibrosis genotypes and alcoholic pancreatitis. J Gastroenterol Hepatol 1998, 13:496-499.
45. Monaghan KG, Jackson CE: KuKuruga DL, et al.: Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis. Am J Med Genet 2000, 94:120-124.
46. Malats N, Casals T, Porta M, et al.: Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Gut 2001, 48:70-74.
47. Witt H, Luck W, Becker M, et al.: Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA 2001, 285:2716-2717.
48. Apte MV, Phillips PA, Fahmy RG, et al.: Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology 2000, 118:780-794.
49. Masamune A, Kikuta K, Satoh M, et al.: Alcohol activates activator protein-1 and mitogen-activated protein kinases in rat pancreatic stellate cells. J Pharmacol Exp Ther 2002, 302:36-42.
50. Jaster R, Brock P, Sparmann G, et al.: Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin. Biochem Pharmacol 2003, 7603:1-9. Lovastatin is shown to inhibit the activation of pancreatic stellate cells in culture and offers the promise of a novel human therapy for chronic pancreatitis.
51. Tysk C, Al-Eryani AY, Shawabkeh AA: Acute pancreatitis induced by fluvastatin therapy. J Clin Gastroenterol 2002, 35:406-408.
52. Phillips PA, McCarroll JA, Park S, et al.: Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover. Gut 2003, 52:275-282.
53. Zimmermann A, Gloor B, Kappeler A, et al.: Pancreatic stellate cells contribute to regeneration early after acute necrotising pancreatitis in humans. Gut 2002, 51:574-578.
54. Hamano H, Kawa S, Horiuchi A, et al.: High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001, 344:732-738.
55. Chen RY, Adams DB: IgG4 levels in non-Japanese patients with autoimmune scferosing pancreatitis. N Engl J Med 2002, 346:1919.
56. Kawa S, Ota M, Yoshizawa K, et al.: HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002, 122:1264-1269.
57. Okazaki K, Chiba T: Autoimmune related pancreatitis. Gut 2002, 51:1-4.
58. Kahl S, Glasbrenner B, Leodolter A, et al.: EUS in the diagnosis of early chronic pancreatitis: a prospective follow-up study. Gastrointest Endosc 2002, 55:507-511.
59. Kodama T, Koshitani T, Sato H, et al.: Electronic pancreatoscopy for the diagnosis of pancreatic diseases. Am J Gastroenterol 2002, 97:617-622.
60. Hardt PD, Marzeion AM, Schnell-Kretschmer H, et al.: Fecal elastase 1 measurement compared with endoscopic retrograde cholangiopancreatography for the diagnosis of chronic pancreatitis. Pancreas 2002, 25:e6-e9.
61. Raimondo M, Imoto M, DiMagno EP: Is a rapid endoscopic secretin stimulation test useful to differentiate patients with pancreatic diseases from disease controls? Pancreas 1999, 19:435.
62. Conwell DL, Zuccaro G, Morrow J B, et al.: Analysis of duodenal drainage fluid after cholecystokinin (CCK) stimulation in healthy volunteers. Pancreas 2002, 25:350-354.
63. Conwell DL, Zuccaro G, Morrow JB, et al.: Cholecystokinin-stimulated peak lipase concentration in duodenal drainage fluid: a new pancreatic function test. Am J Gastroenterol 2002, 97:1392-1397.
64. Conwell DL, Zuccaro G Jr, Vargo JJ, et al.: An endoscopic pancreatic function test with synthetic porcine secretin for the evaluation of chronic abdominal pain and suspected chronic pancreatitis. Gastrointest Endosc 2003, 57:37-40.
65. Malka D, Hammel P, Maire F, et al.: Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 2002, 51:849-852.
66. Howes N, Neoptolemos JP: Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis. Gut 2002, 51:765-766.
67. Kamisawa T, Tu Y, Egawa N, et al.: Salivary gland involvement in chronic pancreatitis of various etiologies. Am J Gastroenterol 2003, 98:323-326.
68. Chowdhury RS, Forsmark CE, Davis RH, et al.: Prevalence of gastroparesis in patients with small duct chronic pancreatitis. Pancreas 2003, 26:235-238.
69. Kozarek RA, Brandabur JJ, Ball TJ, et al.: Clinical outcomes in patients who undergo extracorporeal shock wave lithotripsy for chronic calcific pancreatitis. Gastrointest Endosc 2002, 56:496-500.
70. Farnbacher MJ, Schoen C, Rabenstein T, et al.: Pancreatic duct stones in chronic pancreatitis: criteria for treatment intensity and success. Gastrointest Endosc 2002, 56:501-506.
71. Ammann RW, Muellhaupt B: The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology 1999, 116:1132-1140. [see comments]
72. DiMagno EP: Toward understanding (and management) of painful chronic pancreatitis. Gastroenterology 1999, 116:1252-1257. [editorial; comment]
73. Etemad B, Whitcomb DC: Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001, 120:682-707.
74. Wakabayashi T, Kawaura Y, Satomura Y, et al.: Clinical study of chronic pancreatitis with focal irregular narrowing of the main pancreatic duct and mass formation: comparison with chronic pancreatitis showing diffuse irregular narrowing of the main pancreatic duct. Pancreas 2002, 25:283-289.
75. Cohen S, Bacon BR, Berlin JA, et al.: National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc 2002, 56:803-809. Up-to-date consensus on the role of ERCP for the diagnosis and therapy of pancreatic and biliary diseases.